Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Gaia Sampogna, Filippo Caraci, Claudia Carmassi, Bernardo Dell’Osso, Silvia Ferrari, Giovanni Martinotti, Gabriele Sani, Gianluca Serafini, Maria Salvina Signorelli & Andrea Fiorillo. (2023) Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper. Expert Opinion on Pharmacotherapy 24:14, pages 1511-1525.
Read now
Read now
Luca Diamanti, Elisa Bianchi, Klodjana Mucaj, Cristina Cereda, Silvio Garattini, Ettore Beghi & Elisabetta Pupillo. (2022) Drug treatments and interactions, disease progression and quality of life in ALS patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 415-423.
Read now
Read now
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now
Read now
Xiaobei Dong, Chi Chun Steve Tsang, Shirong Zhao, Jamie A. Browning, Jim Y. Wan, Marie A. Chisholm-Burns, Christopher K. Finch, Jack W. Tsao, Lisa E. Hines & Junling Wang. (2021) Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer’s disease. Current Medical Research and Opinion 37:9, pages 1581-1588.
Read now
Read now
Dorsa Maher, Nagham Ailabouni, Arduino A. Mangoni, Michael D. Wiese & Emily Reeve. (2021) Alterations in drug disposition in older adults: a focus on geriatric syndromes. Expert Opinion on Drug Metabolism & Toxicology 17:1, pages 41-52.
Read now
Read now
Jeroen S. Kok, Richard C. Oude Voshaar & Erik J. A. Scherder. (2020) Psychotropic drug use in residents with dementia living in small-scaled special care facilities; a longitudinal study. Aging & Mental Health 24:4, pages 689-696.
Read now
Read now
Thitipon Yaowaluk, Vorapun Senanarong, Chanin Limwongse, Rasda Boonprasert & Pornpimol Kijsanayotin. (2019) Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia. Pharmacogenomics and Personalized Medicine 12, pages 209-224.
Read now
Read now
Jiří Masopust, Dita Protopopová, Martin Vališ, Zbyšek Pavelek & Blanka Klímová. (2018) Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review. Neuropsychiatric Disease and Treatment 14, pages 1211-1220.
Read now
Read now
Yvette Low, Sajita Setia & Graca Lima. (2018) Drug–drug interactions involving antidepressants: focus on desvenlafaxine. Neuropsychiatric Disease and Treatment 14, pages 567-580.
Read now
Read now
Ramón Cacabelos. (2018) Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?. Expert Opinion on Drug Discovery 13:6, pages 523-538.
Read now
Read now
Emily Reeve, Shanna C Trenaman, Kenneth Rockwood & Sarah N Hilmer. (2017) Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert Opinion on Drug Metabolism & Toxicology 13:6, pages 651-668.
Read now
Read now
Pasi Lampela, Anna-Maija Tolppanen, Antti Tanskanen, Jari Tiihonen, Piia Lavikainen, Sirpa Hartikainen & Heidi Taipale. (2017) Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer’s disease. Annals of Medicine 49:3, pages 230-239.
Read now
Read now
Articles from other publishers (16)
Rohit Malik, Sunishtha Kalra, Saurabh Bhatia, Ahmed Al Harrasi, Govind Singh, Syam Mohan, Hafiz A. Makeen, Mohammed Albratty, Abdulkarim Meraya, Bojlul Bahar & Murtaza M. Tambuwala. (2022) Overview of therapeutic targets in management of dementia. Biomedicine & Pharmacotherapy 152, pages 113168.
Crossref
Crossref
Anne Sverdrup Efjestad, Hege Ihle-Hansen, Vidar Hjellvik, Knut Engedal & Hege Salvesen Blix. (2022) Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database. Frontiers in Pharmacology 12.
Crossref
Crossref
Beáta Bolerázska & Anna Birková. (2021) Oral manifestations of pharmacological treatment of systemic diseases. Klinická farmakologie a farmacie 35:2, pages 88-93.
Crossref
Crossref
Anya Jafari, Zahra Siavashpour & Mohammad Houshyari. (2021) An Updated Review on Memantine Efficacy in Reducing Cognitive Dysfunction of Whole-brain Irradiation for Adult Patients with Brain metastasis. International Journal of Cancer Management 14:4.
Crossref
Crossref
Valeria Calsolaro, Grazia Daniela Femminella, Sara Rogani, Salvatore Esposito, Riccardo Franchi, Chukwuma Okoye, Giuseppe Rengo & Fabio Monzani. (2021) Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics. Pharmaceuticals 14:3, pages 246.
Crossref
Crossref
Laila KVDr.Dr., Fathima Habeeba TEMohamed Musthafa ADr.Dr., Jobin LouisDr.Dr., Madeeha HabeebullaDr.Dr. & Mohammed Muneersha TK. (2021) EVALUATION OF ADVERSE DRUG REACTIONS IN A TERTIARY CARE CENTER IN SOUTH INDIA-A PROSPECTIVE OBSERVATIONAL STUDY. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 1-3.
Crossref
Crossref
Caterina Trevisan, Federica Limongi, Paola Siviero, Marianna Noale, Andrea Cignarella, Enzo Manzato, Giuseppe Sergi & Stefania Maggi. (2019) Mild polypharmacy and MCI progression in older adults: the mediation effect of drug–drug interactions. Aging Clinical and Experimental Research 33:1, pages 49-56.
Crossref
Crossref
Macrina Tortajada-Soler, Leticia Sánchez-Valdeón, Marta Blanco-Nistal, José Alberto Benítez-Andrades, Cristina Liébana-Presa & Enrique Bayón-Darkistade. (2020) Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer’s Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer’s Disease. International Journal of Environmental Research and Public Health 17:10, pages 3398.
Crossref
Crossref
Miren Ettcheto, Jordi Olloquequi, Elena Sánchez-López, Oriol Busquets, Amanda Cano, Patricia Regina Manzine, Carlos Beas-Zarate, Rubén D. Castro-Torres, Maria Luisa García, Mónica Bulló, Carme Auladell, Jaume Folch & Antonio Camins. (2020) Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Valeria Calsolaro, Rachele Antognoli, Chukwuma Okoye & Fabio Monzani. (2019) The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Jana Martinková, Oľga Kabátová & Silvia Puteková. (2019) Influence of gender on the prevalence of behavioral symptoms in patients with Alzheimer's dementia. Kontakt 21:1, pages 74-79.
Crossref
Crossref
Takashi Matsumoto, Kyoji Sekiguchi, Zenji Kawakami, Junko Watanabe, Kazushige Mizoguchi, Yasushi Ikarashi & Masahiro Yamamoto. (2018) Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan. Molecules 24:1, pages 115.
Crossref
Crossref
Bingyou YangBo LiuYan LiuHua HanHaixue Kuang. (2018)
Cognitive enhancement of volatile oil from the stems of
Schisandra chinensis
Baill. in Alzheimer’s disease rats
. Canadian Journal of Physiology and Pharmacology 96:6, pages 550-555.
Crossref
Crossref
Adam Bucki, Monika Marcinkowska, Joanna Śniecikowska, Krzysztof Więckowski, Maciej Pawłowski, Monika Głuch-Lutwin, Anna Gryboś, Agata Siwek, Karolina Pytka, Magdalena Jastrzębska-Więsek, Anna Partyka, Anna Wesołowska, Paweł Mierzejewski & Marcin Kołaczkowski. (2017)
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1
H
-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity
. Journal of Medicinal Chemistry 60:17, pages 7483-7501.
Crossref
Crossref
Anne Sverdrup Efjestad, Hege Ihle-Hansen, Vidar Hjellvik & Hege Salvesen Blix. (2017) Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors. Dementia and Geriatric Cognitive Disorders Extra 7:1, pages 30-40.
Crossref
Crossref
Felipe Nathanael Coelho Vaz, Luana Bortoluzzi Trombim, Guilherme Barroso L. de Freitas, Maria Vaitsa Loch Haskel, Giovana dos Santos, Jéssica Wouk, Dayanna Hartmann Cambruzzi Mendes, Barbara Luisa Fermino, Flávia Ivanski & Juliana Sartori Bonini. (2017) Polypharmacy in Alzheimer's disease patients in Brazil: Guidance for pharmaceutical assistance. F1000Research 6, pages 2068.
Crossref
Crossref